- ATMI (ATMI) has agreed to sell its LifeSciences unit to Pall Corp. (PLL) in a deal worth $185M, with after-tax proceeds to be $165M.
- The sale is part of ATMI's "ongoing exploration of strategic alternatives," the company said.
- The assets of the LifeSciences business include two Belgian sites and a shared facility in Minnesota. (PR)
ATMI to sell LifeSciences ops to Pall for $185M
Dec 23 2013, 07:32 ET